Significant Morbidity and Mortality Attributable toRothia MucilaginosaInfections in Children with Hematological Malignancies or Following Hematopoietic Stem Cell Transplantation
- 9 May 2013
- journal article
- case report
- Published by Taylor & Francis Ltd in Pediatric Hematology and Oncology
- Vol. 30 (5), 445-454
- https://doi.org/10.3109/08880018.2013.783893
Abstract
Rothia mucilaginosa is a gram-positive coccus that poses a diagnostic challenge and often requires DNA pyrosequencing for diagnosis as it can be easily mistaken for coagulase-negative staphylococci on initial culture results. While it is often times normal human oral and upper respiratory tract microbiota, it can be a virulent pathogen in immunocompromised patients. Most commonly, it causes bacteremia (catheter and non-catheter related) and meningitis in these patients. Our objective was to report the incidence of R. mucilaginosa infections in neutropenic children with hematological malignancies or following hematopoietic stem cell transplantation at a major children's hospital. We report 11 patients in this cohort who developed clinically significant R. mucilaginosa infections, including three deaths directly attributable to this microorganism. Three patients developed significant neurological involvement, accounting for two of the deaths, and one patient died of disseminated infection. Except for one, all patients had severe neutropenia, central line catheters, and mucosal breakdown at the time of infection. Patients who succumbed never achieved neutrophil recovery. In conclusion, R. mucilaginosa can lead to life-threatening infections in immunocompromised hosts, especially in profoundly neutropenic patients.Keywords
This publication has 19 references indexed in Scilit:
- Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progressionHaematologica, 2008
- Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantationPediatric Blood & Cancer, 2008
- DNA Pyrosequencing-Based Bacterial Pathogen Identification in a Pediatric Hospital SettingJournal of Clinical Microbiology, 2007
- Central Nervous System Infections Due toStomatococcus mucilaginosusin Immunocompromised HostsClinical Infectious Diseases, 1998
- Successful Treatment of Stomatococcus mucilaginosus Meningitis with Intravenous Vancomycin and Intravenous CeftriaxoneClinical Infectious Diseases, 1997
- ReplyThe Pediatric Infectious Disease Journal, 1995
- Cross-reactivity between Stomatococcus mucilaginosus and latex agglutination for cryptococcal antigenThe Lancet, 1993
- Complications of Bacteremia Due to Stomatococcus mucilaginosus in Neutropenic ChildrenClinical Infectious Diseases, 1993
- Stomatococcus mucilaginosus Meningitis in a Child with LeukemiaClinical Infectious Diseases, 1992
- Bacteremia caused byStomatococcus mucilaginosus: Report of seven cases and review of the literatureInfection, 1992